Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
about
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.Optimization of linezolid treatment regimens for Gram-positive bacterial infections based on pharmacokinetic/pharmacodynamic analysis.Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic reviewSystematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact.Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention.Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation.
P2860
Q36802059-EEF228AA-9D37-444C-BB10-39A44F322F21Q38604890-57405A63-A297-4A67-93C1-11C4992EAB33Q38777085-357A0D30-928D-4106-9B02-D6F3DF029465Q38786623-A7626C70-CD4D-4EF8-9AE4-17D15A7E0F7DQ39013332-9159A429-900A-4822-BFA7-7EFEA7BEC57BQ40121784-78C396E9-8132-46CD-ACAA-BCC6EA3015BCQ48108947-243C0CF9-3EF3-49FA-98C8-8BE1A6F91C33Q50719557-A3F6D3A7-E972-4BBD-BF2C-5BB0ED776A0EQ53401178-7F72CB7C-2B41-406E-969D-58EF358302D3Q55345417-0403D134-D9E0-4391-946C-2551D9C72281
P2860
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pharmacokinetic/pharmacodynami ...... ng and Monte Carlo simulation.
@en
type
label
Pharmacokinetic/pharmacodynami ...... ng and Monte Carlo simulation.
@en
prefLabel
Pharmacokinetic/pharmacodynami ...... ng and Monte Carlo simulation.
@en
P50
P356
P1476
Pharmacokinetic/pharmacodynami ...... ing and Monte Carlo simulation
@en
P2093
Giovanni Crichiutti
Miriam Isola
P304
P356
10.1093/JAC/DKU337
P407
P577
2014-09-01T00:00:00Z